Published in

Taylor and Francis Group, Scandinavian Journal of Rheumatology, 5(47), p. 418-421, 2018

DOI: 10.1080/03009742.2017.1376110

Links

Tools

Export citation

Search in Google Scholar

Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO